Search Results for "Mylan Atovaquone And Proguanil 250mg 100mg Tablet"

10:47 EDT 23rd September 2017 | BioPortfolio

Matching Channels

Selective monoamine oxidase type B MAOB inhibitors

The clinical benefit of monoamine oxidase type B (MAO-B) inhibitors is thought to arise from an ability of these medications to enhance the level of dopamine by decreasing the catabolism. Additional...

Matching News

Glenmark secures UK MHRA approval for anti-malarial medication

Glenmark Pharmaceuticals Europe (Glenmark) has secured final approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Maloff Protect, its range of atovaquone / proguanil ...

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved updated labeling for Epclusa (sofosbuvir 400mg/velpatasvir 100mg), the first all-oral, pan-genotypic, once...

Mylan Finalizes Settlement Agreement On EpiPen Auto-Injector

CANONSBURG (dpa-AFX) - Mylan N.V. (MYL) said that its subsidiaries, Mylan Inc. and Mylan Specialty L.P., have signed an agreement with the U.S. Department of Justice and two relators finalizing th...

Das Caterpillar® T20 Tablet: Ein robustes Tablet für härteste Einsatzbedingungen

Berlin (ots/PRNewswire) - Auf der IFA 2017 präsentiert Caterpillar sein erstes Rugged Tablet, das in Kürze für EUR 649 (inkl. MwSt.) auf den Markt kommen wird. Das robuste Tablet läuft unter dem B...

The Caterpillar® T20 Tablet: A Rugged Tablet for Tough Work Conditions

BERLIN, August 31, 2017 /PRNewswire/ -- Caterpillar is bringing its first rugged tablet to the market, with a list price of EUR 649 (including value-added tax). The rugged tablet, with a Windows 1...

Mylan: Time To Sell?

Mylan has reduced its 2017 financial guidance and continues to face high level of pricing erosion for its generics business. Since 2016, Mylan has been in the news for all the wrong reasons.

No more import of 49 medicines; Local manufacturers to fill gap

The local pharmaceutical industry has been given a big boost following the government's decision to ban the importation of 49 medicines which have now been reserved for local manufacturers. Notice...

Gilead Reports Authorization Of Vosevi, Extended Indication For Harvoni In EU

FOSTER CITY (dpa-AFX) - Gilead Sciences, Inc. (GILD) announced the European Commission has granted marketing authorization for Vosevi (sofosbuvir 400mg/velpatasvir 100mg/voxilaprevir 100mg), as a ...

Matching PubMed Articles

Acute malaria infection after atovaquone-proguanil prophylaxis.

Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.

This study was designed to develop a once-daily controlled-release matrix tablet of aceclofenac 200mg (AFC-CR) with dual release characteristics and to investigate the role of an alkalizer in enhancin...

Multispectral UV imaging for determination of the tablet coating thickness.

The applicability of off-line multispectral ultraviolet (UV) imaging in combination with multivariate data analysis was investigated to determine the coating thickness and its distribution on the tabl...

Development and evaluation of a dimensionless mechanistic pan coating model for the prediction of coated tablet appearance.

A mathematical, mechanistic tablet film-coating model has been developed for pharmaceutical pan coating systems based on the mechanisms of atomisation, tablet bed movement and droplet drying with the ...

HIV update: Which single-tablet regimens, and when.

With the approval of single-tablet regimens that contain 3 or 4 drugs, many patients take just one pill a day. So what are the options and what's on the horizon?

Search Whole site using Google

Quick Search
Advertisement Advertisement